• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病导致骨髓自主神经病变,并通过失调的 p66Shc 和 Sirt1 损害干细胞动员。

Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1.

机构信息

Venetian Institute of Molecular Medicine, Padova, Italy.

出版信息

Diabetes. 2014 Apr;63(4):1353-65. doi: 10.2337/db13-0894. Epub 2013 Nov 22.

DOI:10.2337/db13-0894
PMID:24270983
Abstract

Diabetes compromises the bone marrow (BM) microenvironment and reduces the number of circulating CD34(+) cells. Diabetic autonomic neuropathy (DAN) may impact the BM, because the sympathetic nervous system is prominently involved in BM stem cell trafficking. We hypothesize that neuropathy of the BM affects stem cell mobilization and vascular recovery after ischemia in patients with diabetes. We report that, in patients, cardiovascular DAN was associated with fewer circulating CD34(+) cells. Experimental diabetes (streptozotocin-induced and ob/ob mice) or chemical sympathectomy in mice resulted in BM autonomic neuropathy, impaired Lin(-)cKit(+)Sca1(+) (LKS) cell and endothelial progenitor cell (EPC; CD34(+)Flk1(+)) mobilization, and vascular recovery after ischemia. DAN increased the expression of the 66-kDa protein from the src homology and collagen homology domain (p66Shc) and reduced the expression of sirtuin 1 (Sirt1) in mice and humans. p66Shc knockout (KO) in diabetic mice prevented DAN in the BM, and rescued defective LKS cell and EPC mobilization. Hematopoietic Sirt1 KO mimicked the diabetic mobilization defect, whereas hematopoietic Sirt1 overexpression in diabetes rescued defective mobilization and vascular repair. Through p66Shc and Sirt1, diabetes and sympathectomy elevated the expression of various adhesion molecules, including CD62L. CD62L KO partially rescued the defective stem/progenitor cell mobilization. In conclusion, autonomic neuropathy in the BM impairs stem cell mobilization in diabetes with dysregulation of the life-span regulators p66Shc and Sirt1.

摘要

糖尿病会损害骨髓(BM)微环境并减少循环 CD34(+)细胞的数量。糖尿病自主神经病变(DAN)可能会影响 BM,因为交感神经系统在 BM 干细胞迁移中起着重要作用。我们假设 BM 神经病变会影响糖尿病患者缺血后的干细胞动员和血管恢复。我们报告称,在患者中,心血管 DAN 与循环 CD34(+)细胞数量减少有关。实验性糖尿病(链脲佐菌素诱导和 ob/ob 小鼠)或小鼠的化学性交感神经切除术导致 BM 自主神经病变,损害 Lin(-)cKit(+)Sca1(+)(LKS)细胞和内皮祖细胞(EPC;CD34(+)Flk1(+))动员以及缺血后的血管恢复。DAN 增加了 src 同源和胶原同源结构域(p66Shc)的 66 kDa 蛋白的表达,并降低了小鼠和人类中的 Sirtuin 1(Sirt1)的表达。糖尿病小鼠中的 p66Shc 敲除(KO)可防止 DAN 在 BM 中发生,并挽救了 LKS 细胞和 EPC 动员的缺陷。造血 Sirt1 KO 模拟了糖尿病动员缺陷,而糖尿病中造血 Sirt1 的过表达则挽救了动员缺陷和血管修复。通过 p66Shc 和 Sirt1,糖尿病和交感神经切除术提高了各种粘附分子的表达,包括 CD62L。CD62L KO 部分挽救了缺陷性干细胞/祖细胞动员。总之,BM 中的自主神经病变会损害糖尿病中的干细胞动员,其调节寿命调节剂 p66Shc 和 Sirt1 的失调。

相似文献

1
Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1.糖尿病导致骨髓自主神经病变,并通过失调的 p66Shc 和 Sirt1 损害干细胞动员。
Diabetes. 2014 Apr;63(4):1353-65. doi: 10.2337/db13-0894. Epub 2013 Nov 22.
2
Diabetes gets on the nerves of the bone marrow niche.糖尿病影响骨髓微环境。
Diabetes. 2014 Apr;63(4):1185-7. doi: 10.2337/db13-1931.
3
Diabetes-Associated Myelopoiesis Drives Stem Cell Mobilopathy Through an OSM-p66Shc Signaling Pathway.糖尿病相关的骨髓造血作用通过 OSM-p66Shc 信号通路驱动干细胞动员异常。
Diabetes. 2019 Jun;68(6):1303-1314. doi: 10.2337/db19-0080. Epub 2019 Apr 1.
4
Diabetes impairs mobilization of mouse bone marrow-derived Lin(-)/VEGF-R2(+) progenitor cells.糖尿病可损害小鼠骨髓来源的 Lin(-)/VEGF-R2(+)祖细胞的动员。
Blood Cells Mol Dis. 2013 Oct;51(3):163-73. doi: 10.1016/j.bcmd.2013.05.002. Epub 2013 May 25.
5
Hematopoietic and Nonhematopoietic Differentially Regulates Stem Cell Traffic and Vascular Response to Ischemia in Diabetes.造血与非造血对糖尿病中干细胞运输及血管缺血反应的差异调节
Antioxid Redox Signal. 2022 Apr;36(10-12):593-607. doi: 10.1089/ars.2021.0097. Epub 2022 Jan 4.
6
Pharmacologic PPAR-γ Activation Reprograms Bone Marrow Macrophages and Partially Rescues HSPC Mobilization in Human and Murine Diabetes.药物激活过氧化物酶体增殖物激活受体-γ可重塑骨髓巨噬细胞,并部分挽救人类和小鼠糖尿病中的 HSPC 动员。
Diabetes. 2020 Jul;69(7):1562-1572. doi: 10.2337/db19-0640. Epub 2020 Apr 28.
7
Endothelium-specific SIRT1 overexpression inhibits hyperglycemia-induced upregulation of vascular cell senescence.内皮细胞特异性 SIRT1 过表达抑制高血糖诱导的血管细胞衰老。
Sci China Life Sci. 2012 Jun;55(6):467-73. doi: 10.1007/s11427-012-4329-4. Epub 2012 Jun 29.
8
Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction.SIRT1 通过抑制 P66Shc 的表达来预防高血糖诱导的内皮功能障碍。
Circ Res. 2011 Sep 2;109(6):639-48. doi: 10.1161/CIRCRESAHA.111.243592. Epub 2011 Jul 21.
9
P66Shc-Induced MicroRNA-34a Causes Diabetic Endothelial Dysfunction by Downregulating Sirtuin1.P66Shc诱导的微小RNA-34a通过下调沉默调节蛋白1导致糖尿病性内皮功能障碍。
Arterioscler Thromb Vasc Biol. 2016 Dec;36(12):2394-2403. doi: 10.1161/ATVBAHA.116.308321. Epub 2016 Oct 27.
10
Salvianolic acid A preconditioning confers protection against concanavalin A-induced liver injury through SIRT1-mediated repression of p66shc in mice.丹酚酸 A 预处理通过 SIRT1 介导的 p66shc 抑制作用保护小鼠免受刀豆蛋白 A 诱导的肝损伤。
Toxicol Appl Pharmacol. 2013 Nov 15;273(1):68-76. doi: 10.1016/j.taap.2013.08.021. Epub 2013 Aug 28.

引用本文的文献

1
Bone Marrow Niche in Cardiometabolic Disease: Mechanisms and Therapeutic Potential.心血管代谢疾病中的骨髓微环境:机制与治疗潜力
Circ Res. 2025 Jan 31;136(3):325-353. doi: 10.1161/CIRCRESAHA.124.323778. Epub 2025 Jan 30.
2
Emerging insights into epigenetics and hematopoietic stem cell trafficking in age-related hematological malignancies.衰老相关血液系统恶性肿瘤中表观遗传学和造血干细胞归巢的新认识。
Stem Cell Res Ther. 2024 Nov 6;15(1):401. doi: 10.1186/s13287-024-04008-4.
3
Single-cell RNA sequencing reveals a distinct profile of bone immune microenvironment and decreased osteoclast differentiation in type 2 diabetic mice.
单细胞RNA测序揭示了2型糖尿病小鼠骨免疫微环境的独特特征以及破骨细胞分化减少的情况。
Genes Dis. 2023 Oct 17;11(6):101145. doi: 10.1016/j.gendis.2023.101145. eCollection 2024 Nov.
4
Systemic and local regulation of hematopoietic homeostasis in health and disease.系统和局部调节造血稳态在健康和疾病中的作用。
Nat Cardiovasc Res. 2024 Jun;3(6):651-665. doi: 10.1038/s44161-024-00482-4. Epub 2024 Jun 12.
5
Role of Neurotransmitters in Steady State Hematopoiesis, Aging, and Leukemia.神经递质在稳态造血、衰老和白血病中的作用。
Stem Cell Rev Rep. 2025 Jan;21(1):2-27. doi: 10.1007/s12015-024-10761-z. Epub 2024 Jul 8.
6
The p66 Redox Protein and the Emerging Complications of Diabetes.p66 氧化还原蛋白与糖尿病的新并发症
Int J Mol Sci. 2023 Dec 20;25(1):108. doi: 10.3390/ijms25010108.
7
The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk.衰老和氧化应激对代谢和神经系统疾病的影响:程序性细胞死亡和分子信号转导的串扰。
Front Immunol. 2023 Nov 8;14:1273570. doi: 10.3389/fimmu.2023.1273570. eCollection 2023.
8
Unveiling the Genetic Footprint: Exploring Somatic Mutations in Peripheral Arterial Disease Progression.揭示基因印记:探索外周动脉疾病进展中的体细胞突变
Biomedicines. 2023 Aug 17;11(8):2288. doi: 10.3390/biomedicines11082288.
9
The Metabolic Basis for Nervous System Dysfunction in Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.阿尔茨海默病、帕金森病和亨廷顿病的神经系统功能障碍的代谢基础。
Curr Neurovasc Res. 2023;20(3):314-333. doi: 10.2174/1567202620666230721122957.
10
Cutaneous changes in diabetic patients: Primed for aberrant healing?糖尿病患者的皮肤变化:是否有利于异常愈合?
Wound Repair Regen. 2023 Sep-Oct;31(5):700-712. doi: 10.1111/wrr.13108. Epub 2023 Jul 19.